Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Ballard Power Systems Inc. (NASDAQ: BLDP)(TSX: BLD) shares spiked 18.27 percent to close at $2.46 a share Friday. The stock traded between $2.32 and $2.56 on volume of 8.08 million shares traded. The company announced the sale of approximately 400 kilowatts (kW) of its FCgen-1300 fuel cell stack product to M-Field Energy Ltd. Shares of Ballard Power Systems have gained approximately 230.0 percent in the past year.
Get more information on Ballard Power Systems and free access to the in-depth equity report at:
Galectin Therapeutics Inc. (NASDAQ: GALT) shares jumped 11.93 percent to close at $15.10 a share Friday. The stock traded between $14.78 and $17.88 on volume 7.25 million shares traded. The company announced it sold 2,391,204 shares of common stock at an average price per share of $9.99 from October 28, 2013 through January 9, 2014. Shares of Galectin Therapeutics have gained approximately 600.0 percent in the past year.
Get more information on Galectin Therapeutics and free access to the in-depth equity report at:
Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) shares gained 18.53 percent to close at $28.91 a share Friday. The stock traded between $23.00 and $29.20 on volume 1.36 million shares traded. MLV & Co. have recently initiated coverage on the company with a “buy” rating. Shares of Oramed Pharmaceuticals have gained approximately 85.0 percent year-to-date.
Get more information on Oramed Pharmaceuticals and free access to the in-depth equity report at:
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) shares surged 27.60 percent to close at $7.35 a share Friday. The stock traded between $5.76 and $7.40 on volume 5.87 million shares traded. The company is scheduled to present at the OneMedForum on Monday, January 13th and the Biotech Showcase 2014 Conference on Wednesday, January 15th. Shares of Oxygen Biotherapeutics have fallen approximately 50.0 percent in the past year.
Get more information on Oxygen Biotherapeutics free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities